𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The regulation of osteogenesis by ECM rigidity in MC3T3-E1 cells requires MAPK activation

✍ Scribed by Chirag B. Khatiwala; Shelly R. Peyton; Mark Metzke; Andrew J. Putnam


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
591 KB
Volume
211
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Once thought to provide only structural support to tissues by acting as a scaffold to which cells bind, it is now widely recognized that the extracellular matrix (ECM) provides instructive signals that dictate cell behavior. Recently we demonstrated that mechanical cues intrinsic to the ECM directly regulate the behavior of pre‐osteoblastic MC3T3‐E1 cells. We hypothesized that one possible mechanism by which ECM compliance exerts its influence on osteogenesis is by modulating the mitogen‐activated protein kinase (MAPK) pathway. To address this hypothesis, the differentiation of MC3T3‐E1 cells cultured on poly(ethylene glycol) (PEG)‐based model substrates with tunable mechanical properties was assessed. Alkaline phosphatase (ALP) levels at days 7 and 14 were found to be significantly higher in cells grown on stiffer substrates (423.9 kPa hydrogels and rigid tissue culture polystyrene (TCPS) control) than on a soft hydrogel (13.7 kPa). Osteocalcin (OCN) and bone sialoprotein (BSP) gene expression levels followed a similar trend. In parallel, MAPK activity was significantly higher in cells cultured on stiffer substrates at both time points. Inhibiting this activation pharmacologically, using PD98059, resulted in significantly lower ALP levels, OCN, and BSP gene expression levels on the hydrogels. Interestingly, the effectiveness of PD98059 was itself dependent on substrate stiffness, with marked inhibition of MAPK phosphorylation in cells grown on compliant hydrogels but insignificant reduction in cells grown on TCPS. Together, these data confirm a role for MAPK in the regulation of osteogenic differentiation by ECM compliance. J. Cell. Physiol. 211: 661–672, 2007. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


The heparan sulfate proteoglycan (HSPG)
✍ Larisa M. Haupt; Sadasivam Murali; Foong Kin Mun; Nadiya Teplyuk; Leong Fong Mei 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB 👁 2 views

## Abstract Heparan sulfate (HS) sugar chains attached to core proteoglycans (PGs) termed HSPGs mediate an extensive range of cell–extracellular matrix (ECM) and growth factor interactions based upon their sulfation patterns. When compared with non‐osteogenic (maintenance media) culture conditions,

Heparan sulfate regulates the anabolic a
✍ Rebecca A. Jackson; Sadasivam Murali; Andre J. van Wijnen; Gary S. Stein; Victor 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 562 KB

## Abstract The transcription factor Runx2 can be controlled by a number of upstream regulators involved in intracellular signalling, including the activation ERK1/2 signaling by fibroblast growth factor‐2 (FGF‐2). FGFs interact with their cell surface receptors (FGFRs) through an obligate cross‐bi

Regulation of osteoblast differentiation
✍ Mi Kyeong Lee; Hosoon Choi; Minchan Gil; Vera M. Nikodem 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Abstract The orphan nuclear receptor Nurr1 is primarily expressed in the central nervous system. It has been shown that Nurr1 is necessary for terminal differentiation of dopaminergic (DA) neurons in ventral midbrain. The receptor, however, is also expressed in other organs including bone, even

Induction of osteoblast differentiation
✍ Toyonobu Maeda; Ayako Matsunuma; Izuru Kurahashi; Toru Yanagawa; Hiroshi Yoshida 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB 👁 1 views

## Abstract Statins inhibit 3‐hydroxy‐3‐methylglutaryl‐coenzyme A (HMG‐CoA) reductase, which catalyzes conversion of HMG‐CoA to mevalonate, a rate‐limiting step in cholesterol synthesis. The present study was undertaken to understand the events of osteoblast differentiation induced by statins. Simv